News

Everest Medicines and Singapore's Experimental Drug Development Centre (EDDC) entered a global licensing agreement under which Everest will obtain exclusive worldwide rights to develop, manufacture and commercialize EDDC's series of viral 3C-like (3CL) protease inhibitors as potentially best-in-class COVID-19...

Neurimmune AG announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilizing Neurimmune’s proprietary...

INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables and seeking to deliver better customer experiences in the CDMO market, is nearing completion on the construction of its manufacturing facility and global headquarters...

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO), announced it will be expanding its capacity for purification and fractionation of GMP manufacturing at its site in Södertälje, Sweden. The expansion will satisfy long-term demand expected from Novavax...

After topping off supplies to Pfizer and GlaxoSmithkline, of the COVID-19 vaccine, US has sought AstraZeneca’s help of its antibody combo. Notably, the government has already bought another 500,000 doses of antibody cocktail Evusheld plus cilgavimab. This is in...

The phase 2 EMPATHY top-line data which is a DARP in therapeutic antiviral used in the COVID-19 treatment suggests that measurable and meaningful benefits were seen from Ensovibep over the placebo. The trial is being conducted by Novartis and...

According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron in the next couple of months. As per one of the top line directors at...